Each filer's latest filing for 690145107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Perceptive Advisors LLC
13G
|
9.5% |
2/28/2025
Event 1/8/2025
|
||
| Perceptive Advisors LLC | 9.5% | |||
| Joseph Edelman | 9.5% | |||
| Perceptive Credit Advisors LLC | 9.5% | |||
| Perceptive Credit Holdings IV, LP | 9.5% | |||
|
FMR LLC
13G/A
|
7.0% |
2/12/2025
Event 12/31/2024
|
||
| FMR LLC | 7.0% | |||
| Abigail P. Johnson | 7.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Durable Capital Partners LP
13G
Amended
under CUSIP
690145206
on 11/14/2025
|
9.9% |
1/10/2025
Event 1/3/2025
|
||
|
Alyeska Investment Group, L.P.
13G
|
9.6% |
5/15/2025
Event 3/31/2025
|
||
| Alyeska Investment Group, L.P. | 9.6% | |||
| Alyeska Fund GP, LLC | 9.6% | |||
| Anand Parekh | 9.6% | |||
| Vanguard Group Inc 13G/A | 4.96% |
1/31/2025
Event 12/31/2024
|
||
|
PFM Health Sciences, LP
13G/A
|
2.9% |
2/17/2026
Event 12/31/2025
|
||
| PFM Health Sciences, LP | 2.9% | |||
| PFM Health Sciences GP, LLC | 2.9% | |||
| PFM Healthcare Growth Equity I GP, LLC | 2.9% | |||
| Partner Asset Management, LLC | 2.9% | |||
| Brian D. Grossman | 2.9% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 2 | 99.4 k | $389k |
| 2025 Q4 | 3 | 197 k | $738k |
| 2025 Q3 | 3 | 177 k | $2.50M |
| 2025 Q2 | 2 | 34.7 k | $668k |
| 2025 Q1 | 2 | 24.6 k | $272k |
| 2024 Q4 | 76 | 21.1 M | $23.4M |
| 2024 Q3 | 81 | 26.1 M | $17.6M |
| 2024 Q2 | 124 | 48.6 M | $187M |
| 2024 Q1 | 115 | 50.5 M | $113M |
| 2023 Q4 | 141 | 53.0 M | $287M |
| 2023 Q3 | 154 | 53.8 M | $584M |
| 2023 Q2 | 156 | 53.0 M | $1.16B |
| 2023 Q1 | 164 | 52.0 M | $957M |
| 2022 Q4 | 156 | 49.0 M | $1.27B |
| 2022 Q3 | 140 | 47.7 M | $760M |
| 2022 Q2 | 154 | 48.5 M | $721M |
| 2022 Q1 | 156 | 51.3 M | $2.33B |
| 2021 Q4 | 159 | 48.6 M | $2.24B |
| 2021 Q3 | 144 | 50.7 M | $2.51B |
| 2021 Q2 | 131 | 46.3 M | $2.31B |
| 2021 Q1 | 112 | 38.4 M | $2.09B |
| 2020 Q4 | 112 | 37.4 M | $2.09B |
| 2020 Q3 | 86 | 36.2 M | $1.76B |